MicroRNA-384 inhibits the progression of breast cancer by targeting ACVR1

Breast cancer is the leading cause of cancer-related deaths in females worldwide. Triple-negative breast cancer (TNBC) accounts for 15% of all breast cancer cases and has a poorer prognosis than other subtypes. Moreover, the treatment for breast cancer, especially for TNBC, remains unsatisfactory. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yongxia, Zhang, Zheying, Wang, Jianqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2018
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983929/
https://www.ncbi.nlm.nih.gov/pubmed/29693185
http://dx.doi.org/10.3892/or.2018.6385

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983929/
https://www.ncbi.nlm.nih.gov/pubmed/29693185
http://dx.doi.org/10.3892/or.2018.6385

Ejemplares similares